The preventative health sector just saw a significant boost, with Everlab securing $65.0M in Series A funding. The startup is building what it describes as "the preventative health service of the future," aiming to empower individuals to detect, prevent, and reverse disease risk years before symptoms even show.
Everlab's platform offers access to cutting-edge diagnostics, world-class clinicians, and actionable medical interventions. This comprehensive approach is designed to provide a proactive pathway to health, moving beyond reactive treatment to long-term wellness.















